The FDA linked 12 severe kidney complications to alli between 2007 and 2023, resulting in 8 hospitalizations and 5 patients requiring dialysis. The Food and Drug Administration (FDA) has updated the ...

For months at Erlanger, Sentri7 failed to raise alarms, overlooking missing drugs and other “inconsistencies” that “should have been flagged,” the nursing board’s order states.

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) ...

Significantly longer time seen to first flare that required rescue therapy, and significant benefit seen in all secondary end points.

Bemotrizinol is a newly approved over-the-counter sunscreen active ingredient that offers broad-spectrum protection with low systemic absorption.

A wearable ultrasound patch can provide continuous, real-time information about blood flow in the fetus and umbilical cord, according to a study published online May 26 in Nature Biotechnology. Geonho ...

Phase 3 ISLEND-1 and ISLEND-2 trials met primary endpoints at week 48, showing a novel, once-weekly oral single-tablet regimen is noninferior to daily B/F/TAF or standard ART.

The phase 3 KEYNOTE-D46/EVOKE-03 study evaluated sacituzumab govitecan/pembrolizumab vs pembrolizumab in untreated PD-L1-high metastatic NSCLC.

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

Data show that orforglipron, a once-daily oral GLP-1 receptor agonist, drives significant, long-term weight reduction in women with obesity or overweight across all 3 stages of menopause: premenopause ...

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.